% | $
Quotes you view appear here for quick access.

Astellas Pharma, Inc. Message Board

  • wcoastguy2008 wcoastguy2008 May 4, 2014 12:25 PM Flag

    "CYTK" - Potential Astellas Takeover Target?


    "CYTK" - Cytokinectics - $160M market cap. - $4.46 currently.

    Company has the equivalent of 65% of its market cap in cash on hand and future milestone and royalty payments from Amgen and Astellas two pipeline drugs that could be seven times the current market cap.

    It really is that undervalued.

    p.s. Plus having the potential of a buyout offer at 2-3 times the current share price.

    Needham: $15.00 Price Target - Buy Rating

    This topic is deleted.
13.02+0.28(+2.20%)Oct 9 3:48 PMEDT